These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tuberin nuclear localization can be regulated by phosphorylation of its carboxyl terminus. York B, Lou D, Noonan DJ. Mol Cancer Res; 2006 Nov; 4(11):885-97. PubMed ID: 17114346 [Abstract] [Full Text] [Related]
4. Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis. Sato T, Seyama K, Fujii H, Maruyama H, Setoguchi Y, Iwakami S, Fukuchi Y, Hino O. J Hum Genet; 2002 Nov; 47(1):20-8. PubMed ID: 11829138 [Abstract] [Full Text] [Related]
6. Proteins interacting with the tuberous sclerosis gene products. Rosner M, Freilinger A, Hengstschläger M. Amino Acids; 2004 Oct; 27(2):119-28. PubMed ID: 15351877 [Abstract] [Full Text] [Related]
7. Cloning, developmental expression, and evidence for alternative splicing of the murine tuberous sclerosis (TSC2) gene product. Kim KK, Pajak L, Wang H, Field LJ. Cell Mol Biol Res; 1995 Oct; 41(6):515-26. PubMed ID: 8777431 [Abstract] [Full Text] [Related]
8. Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease. Astrinidis A, Henske EP. Oncogene; 2005 Nov 14; 24(50):7475-81. PubMed ID: 16288294 [Abstract] [Full Text] [Related]
9. Analysis of TSC2 stop codon variants found in tuberous sclerosis patients. Goedbloed MA, Nellist M, Verhaaf B, Reuser AJ, Lindhout D, Sunde L, Verhoef S, Halley DJ, van den Ouweland AM. Eur J Hum Genet; 2001 Nov 14; 9(11):823-8. PubMed ID: 11781698 [Abstract] [Full Text] [Related]
11. Presence of potent transcriptional activation domains in the predisposing tuberous sclerosis (Tsc2) gene product of the Eker rat model. Tsuchiya H, Orimoto K, Kobayashi K, Hino O. Cancer Res; 1996 Feb 01; 56(3):429-33. PubMed ID: 8564946 [Abstract] [Full Text] [Related]
12. Tuberous sclerosis genes regulate cellular 14-3-3 protein levels. Hengstschläger M, Rosner M, Fountoulakis M, Lubec G. Biochem Biophys Res Commun; 2003 Dec 19; 312(3):676-83. PubMed ID: 14680818 [Abstract] [Full Text] [Related]
16. Deletion of 11 amino acids in tuberin associated with severe tuberous sclerosis phenotypes: evidence for a new essential domain in the first third of the protein. Jobert S, Bragado-Nilsson E, Samolyk D, Pedespan JM, Marchal C, Reichert S, Mallet J, Pitiot G. Eur J Hum Genet; 1997 Dec 19; 5(5):280-7. PubMed ID: 9412784 [Abstract] [Full Text] [Related]
17. The tuberous sclerosis 2 gene product can localize to nuclei in a phosphorylation-dependent manner. Lou D, Griffith N, Noonan DJ. Mol Cell Biol Res Commun; 2001 Nov 19; 4(6):374-80. PubMed ID: 11703097 [Abstract] [Full Text] [Related]
18. The spectrum of mutations in TSC1 and TSC2 in women with tuberous sclerosis and lymphangiomyomatosis. Strizheva GD, Carsillo T, Kruger WD, Sullivan EJ, Ryu JH, Henske EP. Am J Respir Crit Care Med; 2001 Jan 19; 163(1):253-8. PubMed ID: 11208653 [Abstract] [Full Text] [Related]
19. Ets protein Elf-1 bidirectionally suppresses transcriptional activities of the tumor suppressor Tsc2 gene and the repair-related Nth1 gene. Honda S, Kobayashi T, Kajino K, Urakami S, Igawa M, Hino O. Mol Carcinog; 2003 Jul 19; 37(3):122-9. PubMed ID: 12884363 [Abstract] [Full Text] [Related]
20. Tuberous sclerosis causing mutants of the TSC2 gene product affect proliferation and p27 expression. Soucek T, Rosner M, Miloloza A, Kubista M, Cheadle JP, Sampson JR, Hengstschläger M. Oncogene; 2001 Aug 09; 20(35):4904-9. PubMed ID: 11521203 [Abstract] [Full Text] [Related] Page: [Next] [New Search]